Quasar Medical to Acquire Nordson MEDICAL Design and Development business in Galway, Ireland and Tecate, Mexico
June 2, 2025 | Quasar MedicalEstimated reading time: 2 minutes
Quasar Medical, a global leader in the manufacturing of interventional and complex minimally invasive devices, announced it has signed a definitive agreement with Nordson Corporation to acquire its design and development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. This will strengthen Quasar’s global position as a full-service Contract Development and Manufacturing Organization (CDMO), offering end-to-end solutions from initial design to large-scale production. The deal is expected to close in the third quarter of calendar 2025.
The Galway and Tecate facilities will be integrated into Quasar’s expanding global platform, adding specialized expertise in complex balloon and catheter design, rapid prototyping, and cost-efficient device near-shore assembly. Both sites provide Quasar with not only advanced know-how and IP-generating capabilities but will also add FDA-registered and ISO-certified facilities and a highly skilled workforce located in two strategic MedTech hubs.
“This is more than a bolt-on acquisition—it marks the next chapter for Quasar,” said Alex Wallstein, CEO of Quasar Medical. “We are now positioned to deliver fully integrated interventional solutions from concept to scale-up finished device, adding significant capacity in Ireland and Mexico to our well-established Asian footprint—diversifying Quasar into a global CDMO partner.”
Dave Zgonc, Vice President of Nordson MEDICAL Interventional Solutions, said, “We’re extremely proud of the highly skilled teams in Galway and Tecate, their expertise, and the customer partnerships they’ve built over the years in our finished device contract manufacturing business. We are thankful for their commitment and dedication to this business.”
Expanded Capabilities, Global Reach
With this acquisition, Quasar Medical now operates 10 facilities across North America, Europe, Israel, and Asia, providing added expertise in design, development, balloon catheter systems, micro-EM sensors, and rapid scale-up of low-cost assembly and manufacturing.
- 800,000 square feet of manufacturing space
- Over 4,200 employees, including over 50 NPD Engineers
- FDA-registered and ISO 13485 certified
- Galway: design, prototyping, and product development, as well as manufacturing
- Tecate: cost-effective, scalable device manufacturing and assembly
Customer Benefits & Strategic Impact
Quasar Medical’s customers will benefit from:
- Integrated design-for-manufacturing and scalable production
- Seamless program transfers and faster market readiness
- Near-shore operations for US customers
- Regionally optimized manufacturing strategies balancing speed, quality, and cost
- Robust quality infrastructure with FDA and ISO 13485 compliance across all facilities
This strategic step expands Quasar’s ability to support global OEMs and innovators with speed, flexibility, innovation, and precision—from concept to prototype to finished device delivery.
Quasar will work closely with Nordson to ensure a smooth transition for all customers and suppliers. Upon closing, the Galway and Tecate sites will be fully integrated into the Quasar platform.
Testimonial
"Advertising in PCB007 Magazine has been a great way to showcase our bare board testers to the right audience. The I-Connect007 team makes the process smooth and professional. We’re proud to be featured in such a trusted publication."
Klaus Koziol - atgSuggested Items
L3Harris Begins Sensor System Manufacturing in Poland
08/26/2025 | L3Harris TechnologiesL3Harris Technologies has begun manufacturing electro-optical/infrared (EO/IR) sensor systems at a 2,000-square-meter facility in Katowice.
Medical Device Contract Manufacturing Market Worth $140.84 Billion by 2030 with 10.9% CAGR
08/25/2025 | PRNewswireThe global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
Intel, Trump Administration Reach Historic Agreement to Accelerate American Technology and Manufacturing Leadership
08/25/2025 | BUSINESS WIREIntel Corporation announced an agreement with the Trump Administration to support the continued expansion of American technology and manufacturing leadership.
The Government Circuit: Navigating New Trade Headwinds and New Partnerships
08/25/2025 | Chris Mitchell -- Column: The Government CircuitAs global trade winds continue to howl, the electronics manufacturing industry finds itself at a critical juncture. After months of warnings, the U.S. Government has implemented a broad array of tariff increases, with fresh duties hitting copper-based products, semiconductors, and imports from many nations. On the positive side, tentative trade agreements with Europe, China, Japan, and other nations are providing at least some clarity and counterbalance.
Missile Strike on Ukraine Hits Flex Facility
08/22/2025 | FlexOn the morning of August 21, 2025, our facility in Mukachevo, Ukraine, was damaged during a missile strike. Our emergency protocols were executed to ensure the full evacuation of the site.